Harms Henrik, Orlikova Barbora, Ji Seungwon, Nesaei-Mosaferan Damun, König Gabriele M, Diederich Marc
Institute for Pharmaceutical Biology, University of Bonn, Nussallee 6, Bonn D-53115, Germany.
Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea.
Mar Drugs. 2015 Aug 6;13(8):4949-66. doi: 10.3390/md13084949.
The Ascomycota Dichotomomyces cejpii was isolated from the marine sponge Callyspongia cf. C. flammea. A new gliotoxin derivative, 6-acetylmonodethiogliotoxin (1) was obtained from fungal extracts. Compounds 2 and 3, methylthio-gliotoxin derivatives were formerly only known as semi-synthetic compounds and are here described as natural products. Additionally the polyketide heveadride (4) was isolated. Compounds 1, 2 and 4 dose-dependently down-regulated TNFα-induced NF-κB activity in human chronic myeloid leukemia cells with IC50s of 38.5 ± 1.2 µM, 65.7 ± 2.0 µM and 82.7 ± 11.3 µM, respectively. The molecular mechanism was studied with the most potent compound 1 and results indicate downstream inhibitory effects targeting binding of NF-κB to DNA. Compound 1 thus demonstrates potential of epimonothiodiketopiperazine-derived compounds for the development of NF-κB inhibitors.
子囊菌纲的切氏双歧菌是从海洋海绵类动物火焰海绵(Callyspongia cf. C. flammea)中分离得到的。从该真菌提取物中获得了一种新的胶霉毒素衍生物,即6-乙酰基单去硫胶霉毒素(1)。化合物2和3,即甲硫基胶霉毒素衍生物,以前仅作为半合成化合物为人所知,在此被描述为天然产物。此外,还分离出了聚酮化合物橡胶二萜(4)。化合物1、2和4在人慢性髓性白血病细胞中呈剂量依赖性下调肿瘤坏死因子α诱导的核因子κB活性,其半数抑制浓度(IC50)分别为38.5±1.2微摩尔、65.7±2.0微摩尔和82.7±11.3微摩尔。使用活性最强的化合物1对分子机制进行了研究,结果表明其下游抑制作用靶向核因子κB与DNA的结合。因此,化合物1证明了表单硫代二酮哌嗪衍生化合物在开发核因子κB抑制剂方面的潜力。